PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...

To speed up drug applications, the FDA has laid out new guidance on how to request a platform designation that can smooth subsequent applications for biotechs working off the same reproducible ...

Ingram Micro is a global technology distributor that generates approximately $48 billion in annual revenue by serving as a critical link between technology vendors and resellers. As the President of ...

Forbes contributors publish independent expert analyses and insights. I track enterprise software application development & data management. Platforms dominate technology. We talk about Microsoft’s ...

Cellugy has developed a platform technology that enables the creation of fully bio-based and biodegradable alternatives to carbon-intensive petrochemicals. Danish industrial biotech startup Cellugy ...